Literature DB >> 12054774

Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.

Markus Kaufmann1, Peter Lindner, Annemarie Honegger, Kerstin Blank, Markus Tschopp, Guido Capitani, Andreas Plückthun, Markus G Grütter.   

Abstract

The crystal structure of a mutant form of the single-chain fragment (scFv), derived from the monoclonal anti-His tag antibody 3D5, in complex with a hexahistidine peptide has been determined at 2.7 A resolution. The peptide binds to a deep pocket formed at the interface of the variable domains of the light and the heavy chain, mainly through hydrophobic interaction to aromatic residues and hydrogen bonds to acidic residues. The antibody recognizes the C-terminal carboxylate group of the peptide as well as the main chain of the last four residues and the last three imidazole side-chains. The crystals have a solvent content of 77% (v/v) and form 70 A-wide channels that would allow the diffusion of peptides or even small proteins. The anti-His scFv crystals could thus act as a framework for the crystallization of His-tagged target proteins. Designed mutations in framework regions of the scFv lead to high-level expression of soluble protein in the periplasm of Escherichia coli. The recombinant anti-His scFv is a convenient detection tool when fused to alkaline phosphatase. When immobilized on a matrix, the antibody can be used for affinity purification of recombinant proteins carrying a very short tag of just three histidine residues, suitable for crystallization. The experimental structure is now the basis for the design of antibodies with even higher stability and affinity. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054774     DOI: 10.1016/S0022-2836(02)00038-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Conversion of scFv peptide-binding specificity for crystal chaperone development.

Authors:  Jennifer C Pai; Jeffrey A Culver; Jason E Drury; Rakesh S Motani; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2011-01-08       Impact factor: 1.650

2.  Structure of anti-FLAG M2 Fab domain and its use in the stabilization of engineered membrane proteins.

Authors:  Tarmo P Roosild; Samantha Castronovo; Senyon Choe
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-18

3.  Structural basis of neutralization of the major toxic component from the scorpion Centruroides noxius Hoffmann by a human-derived single-chain antibody fragment.

Authors:  Juan Carlos Canul-Tec; Lidia Riaño-Umbarila; Enrique Rudiño-Piñera; Baltazar Becerril; Lourival D Possani; Alfredo Torres-Larios
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

4.  L-Asparaginase from Erwinia carotovora: insights about its stability and activity.

Authors:  Marcele Faret; Stephanie Bath de Morais; Nilson Ivo Tonin Zanchin; Tatiana de Arruda Campos Brasil de Souza
Journal:  Mol Biol Rep       Date:  2018-11-16       Impact factor: 2.316

5.  Effects of protein engineering and rational mutagenesis on crystal lattice of single chain antibody fragments.

Authors:  Sibel Kalyoncu; Jeongmin Hyun; Jennifer C Pai; Jennifer L Johnson; Kevin Entzminger; Avni Jain; David P Heaner; Ivan A Morales; Thomas M Truskett; Jennifer A Maynard; Raquel L Lieberman
Journal:  Proteins       Date:  2014-03-24

6.  Aberrantly Large Single-Channel Conductance of Polyhistidine Arm-Containing Protein Nanopores.

Authors:  Avinash Kumar Thakur; Motahareh Ghahari Larimi; Kristin Gooden; Liviu Movileanu
Journal:  Biochemistry       Date:  2017-08-28       Impact factor: 3.162

Review 7.  Crystallization chaperone strategies for membrane proteins.

Authors:  Raquel L Lieberman; Jeffrey A Culver; Kevin C Entzminger; Jennifer C Pai; Jennifer A Maynard
Journal:  Methods       Date:  2011-08-11       Impact factor: 3.608

8.  Sequence-independent processing site of the C-terminal domain (CTD) influences maturation of the RgpB protease from Porphyromonas gingivalis.

Authors:  Xiao-Yan Zhou; Jin-Long Gao; Neil Hunter; Jan Potempa; Ky-Anh Nguyen
Journal:  Mol Microbiol       Date:  2013-07-19       Impact factor: 3.501

Review 9.  Measles virus for cancer therapy.

Authors:  S J Russell; K W Peng
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

10.  Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma.

Authors:  Monique H Verheije; Martine L M Lamfers; Thomas Würdinger; Guy C M Grinwis; Winald R Gerritsen; Victor W van Beusechem; Peter J M Rottier
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.